FDA

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

The Loper Bright decision leaves hundreds of pivotal health care regulations subject to litigation.

Scholar calls for Congress to empower regulators to limit exposure to cancer-causing chemicals.

FDA approves first over-the-counter continuous glucose monitor for U.S. patients.

Contaminated agricultural water is a well-known root cause of foodborne illness that regulators have struggled to address.

FDA proposes a rule that would prohibit the use of a toxic food additive in sodas.

Scholars assess the state of food-additive regulation.

Researchers address the challenges regulators face in protecting the public amid the rapid growth of neurotechnologies.

Scholars and practitioners debate whether and how to regulate off-label drug use.

Scholar recommends that regulators change food label laws to increase consumers’ access to plant-based meats.

The FTC cracks down on improperly listed drug patents, challenging over 100 patent listings.

Dispensaries could fill the regulatory void for psychedelics and promote public health.